Lynch syndrome screening in colorectal and endometrial cancers in Iceland

被引：0
作者：
Kluvers, Katla R. [1 ]
Tryggvason, Thordur [2 ]
Stefansdottir, Vigdis [3 ]
Jonasson, Jon G. [1 ,2 ]
Snaebjornsson, Petur [1 ,4 ]
Haraldsdottira, Sigurdis [1 ,5 ]
机构：
[1] Univ Iceland, Fac Med, Reykjavik, Iceland
[2] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland
[3] Landspitali Univ Hosp, Dept Genet & Mol Med, Reykjavik, Iceland
[4] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[5] Landspitali Univ Hosp, Dept Oncol, Reykjavik, Iceland
来源：
ACTA ONCOLOGICA | 2025年 / 64卷
关键词：
Lynch syndrome; mismatch repair deficiency; MMR; immunohistochemistry; founder variant; cancer genetics;
D O I：
10.2340/1651-226X.2025.41957
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background and purpose: Screening for Lynch syndrome (LS) with mismatch repair (MMR) protein immunohistochemistry (IHC) in all patients with newly diagnosed colorectal (CRC) and endometrial cancer (EC) was implemented in Iceland in 2017. The aim of the study is to assess the accuracy of screening in 2020- 2022 and compare it to 2017-2019 when screening was initiated. Patients/materials and methods: All patients diagnosed with CRC and EC according to the Icelandic Cancer Registry in 2020-2022 were included. Screening results were crossmatched with a genotyping database from deCODE to calculate sensitivity and specificity for LS detection. Results: In 2020-2022, 429 of 522 (82%) diagnosed CRCs were stained and 90 of 106 (85%) ECs, compared to 74% of CRCs and 82% of ECs in 2017-2019. The screening protocol was followed in 90% of cases for CRCs and 95% of cases for ECs compared to 89% and 68% during 2017-2019. The sensitivity of IHC as a screening method for LS was 70% and specificity 88% with a positive and negative predictive value of 8.4% and 99.4%, respectively. Interpretation: Three LS cases were missed with MMR IHC (1 MSH6 and 2 PMS2 carriers), it is possible these patients had sporadic cancers unrelated to their LS carrier status. MSH6 and PMS2 deficiency strongly predicts LS in Iceland.
引用
收藏
页码：188 / 190
页数：3
相关论文
共 10 条
  • [1] Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR., Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications, Clin Genet, 76, 1, pp. 1-18, (2009)
  • [2] Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Et al., Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome, JAMA, 305, 22, pp. 2304-2310, (2011)
  • [3] Abu-Ghazaleh N, Kaushik V, Gorelik A, Jenkins M, Macrae F., Worldwide prevalence of Lynch syndrome in patients with colorectal cancer: Systematic review and meta-analysis, Genet Med, 24, 5, pp. 971-985, (2022)
  • [4] Haraldsdottir S, Rafnar T, Frankel WL, Einarsdottir S, Sigurdsson A, Hampel H, Et al., Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2, Nat Commun, 8, (2017)
  • [5] Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Et al., Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients, Cancer Res, 66, 15, pp. 7810-7817, (2006)
  • [6] Einarsson H, Runarsdottir JR, Tryggvason T, Snaebjornsson P, Smaradottir A, Stefansdottir V, Et al., Universal tumor screening in a population with MSH6-and PMS2-associated Lynch syndrome, Genet Med, 24, 5, pp. 999-1007, (2022)
  • [7] Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, Et al., Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness, Acta Oncol, 51, 7, pp. 880-889, (2012)
  • [8] Gudbjartsson DF, Helgason H, Gudjonsson SA, Zink F, Oddson A, Gylfason A, Et al., Large-scale whole-genome sequencing of the Icelandic population, Nat Genet, 47, 5, pp. 435-444, (2015)
  • [9] Eggertsson HP, Jonsson H, Kristmundsdottir S, Hjartarson E, Kehr B, Masson G, Et al., Graphtyper enables population-scale genotyping using pangenome graphs, Nat Genet, 49, 11, pp. 1654-1660, (2017)
  • [10] Pearlman R, Haraldsdottir S, de la Chapelle A, Jonasson JG, Liyanarachchi S, Frankel WL, Et al., Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome, J Med Genet, 56, 7, pp. 462-470, (2019)
1